Colgate-Palmolive shares jump 5.49% after-hours on better-than-expected Q4 sales and raised 2026 guidance.
ByAinvest
Friday, Jan 30, 2026 5:35 pm ET1min read
CL--
Colgate-Palmolive (CL) surged 5.49% in after-hours trading following stronger-than-expected Q4 organic sales growth of 2.2%, driven by a rebound in Latin America after reformulating a problematic toothpaste product. The company also raised 2026 guidance, forecasting 1%-4% annual organic sales growth and double-digit EPS expansion despite exiting its private label pet food business. While Q4 net sales rose 5.9% and EPS hit $0.95, a $37 million net loss contrasted with prior-year profits, signaling short-term challenges. Investors appeared to focus on stabilization in core markets and confident margin-improvement plans, outweighing near-term risks. The stock’s rally aligns with improved regional performance and optimistic forward-looking metrics, despite caution from management about weak consumer sentiment.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue


Comments
No comments yet